EUVIMEDEUVIMED entdecken
MetaanalyseSystematische ÜbersichtOpen Access · CC BY-NC 4.0

The effect of bolus advisors on glycaemic parameters in adults with diabetes on intensive insulin therapy: A systematic review with meta‐analysis

Elisabeth J den Brok iD, Cecilie H Svensson iD, Maria Panagiotou, Marleen M J van Greevenbroek iD, Peter R Mertens iD, Andriani Vazeou iD, Asimina Mitrakou iD, Konstantinos Makrilakis iD, Gregor H L M Franssen iD, Sander van Kuijk iD, Stephan Proennecke iD, Stavroula Mougiakakou iD und 3 weitere

Diabetes, Obesity and Metabolism · 2024

DOI: 10.1111/dom.15521 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift Diabetes, Obesity and Metabolism, 2024. Verfasst von Elisabeth J den Brok und 14 weiteren Autor:innen. Beteiligte Einrichtung: CARIM School for Cardiovascular Diseases, Maastricht University, Maastricht, The Netherlands. Hauptthemen laut MEDLINE: Insulin, Hypoglycemic Agents, Blood Glucose, Diabetes Mellitus, Type 1. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: European Commission and the Swiss Confederation-State Secretariat for Education, Research and Innovation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

To conduct a systematic review with meta‐analysis to provide a comprehensive synthesis of randomized controlled trials (RCTs) and prospective cohort studies investigating the effects of currently available bolus advisors on glycaemic parameters in adults with diabetes. Materials and Methods An electronic search of PubMed, Embase, CINAHL, Cochrane Library and ClinicalTrials.gov was conducted in December 2022. The risk of bias was assessed using the revised Cochrane Risk of Bias tool. (Standardized) mean difference (MD) was selected to determine the difference in continuous outcomes between the groups. A random‐effects model meta‐analysis and meta‐regression were performed. This systematic review was registered on PROSPERO (CRD42022374588).

Results

A total of 18 RCTs involving 1645 adults (50% females) with a median glycated haemoglobin (HbA1c) concentration of 8.45% (7.95%–9.30%) were included. The majority of participants had type 1 diabetes ( N = 1510, 92%) and were on multiple daily injections ( N = 1173, 71%). Twelve of the 18 trials had low risk of bias. The meta‐analysis of 10 studies with available data on HbA1c showed that the use of a bolus advisor modestly reduced HbA1c compared to standard treatment (MD −011%, 95% confidence interval −0.22 to −0.01; I 2 = 0%). This effect was accompanied by small improvements in low blood glucose index and treatment satisfaction, but not with reductions in hypoglycaemic events or changes in other secondary outcomes.

Conclusion

Use of a bolus advisor is associated with slightly better glucose control and treatment satisfaction in people with diabetes on intensive insulin treatment. Future studies should investigate whether personalizing bolus advisors using artificial intelligence technology can enhance these effects.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

InsulinHypoglycemic AgentsBlood GlucoseDiabetes Mellitus, Type 1Glycated HemoglobinHumansAdultFemaleRandomized Controlled Trials as TopicGlycemic ControlDiabetes Mellitus, Type 2MaleHypoglycemia

Stichwörter der Autor:innen

bolus advisordiabetes type 1diabetes type 2glycaemic controlinsulin therapy

Substanzen

InsulinHypoglycemic AgentsBlood GlucoseGlycated Hemoglobin

Autor:innen und Institutionen

  • CARIM School for Cardiovascular Diseases, Maastricht University, Maastricht, The Netherlands.
  • Department of Endocrinology and Nephrology, Nordsjællands Hospital, Hillerød, Denmark.
  • ARTORG Center for Biomedical Engineering Research, University of Bern, Bern, Switzerland.
  • Department of Kidney and Hypertension Diseases, Diabetology and Endocrinology, Otto-Von-Guericke-Univeristat Magdeburg, Magdeburg, Germany.
  • P & A Kyriakou' Children's Hospital, Athens, Greece.
  • Diabetes Center, National and Kapodistrian University of Athens, Athens, Greece.

ORCID-Profile: Elisabeth J den Brok, Cecilie H Svensson, Marleen M J van Greevenbroek, Peter R Mertens, Andriani Vazeou, Asimina Mitrakou, Konstantinos Makrilakis, Gregor H L M Franssen, Sander van Kuijk, Stephan Proennecke, Stavroula Mougiakakou, Ulrik Pedersen-Bjergaard, Bastiaan E de Galan

Förderung

  • European Commission and the Swiss Confederation-State Secretariat for Education, Research and Innovation

Zitieren

APA

den Brok, E. J., Svensson, C. H., Panagiotou, M., van Greevenbroek, M. M. J., Mertens, P. R., Vazeou, A., Mitrakou, A., Makrilakis, K., Franssen, G. H. L. M., van Kuijk, S., Proennecke, S., Mougiakakou, S., Pedersen-Bjergaard, U., de Galan, B. E., & MELISSA consortium (2024). The effect of bolus advisors on glycaemic parameters in adults with diabetes on intensive insulin therapy: A systematic review with meta‐analysis. Diabetes, Obesity and Metabolism. https://doi.org/10.1111/dom.15521

Vancouver

den Brok EJ, Svensson CH, Panagiotou M, van Greevenbroek MMJ, Mertens PR, Vazeou A, et al. The effect of bolus advisors on glycaemic parameters in adults with diabetes on intensive insulin therapy: A systematic review with meta‐analysis. Diabetes, Obesity and Metabolism. 2024. doi:10.1111/dom.15521

BibTeX
@article{denBrok2024,
  author = {den Brok, Elisabeth J and Svensson, Cecilie H and Panagiotou, Maria and van Greevenbroek, Marleen M J and Mertens, Peter R and Vazeou, Andriani and Mitrakou, Asimina and Makrilakis, Konstantinos and Franssen, Gregor H L M and van Kuijk, Sander and Proennecke, Stephan and Mougiakakou, Stavroula and Pedersen-Bjergaard, Ulrik and de Galan, Bastiaan E and MELISSA consortium, MELISSA consortium},
  title = {The effect of bolus advisors on glycaemic parameters in adults with diabetes on intensive insulin therapy: A systematic review with meta‐analysis},
  journal = {Diabetes, Obesity and Metabolism},
  year = {2024},
  doi = {10.1111/dom.15521}
}
Kostenlos starten →